Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma-Reference-Cited by-同舟云学术

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma

Published:2007-06-15 Issue:12 Volume:109 Page:2481-2489
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Jabbour Elias,Hosing Chitra,Ayers Gregory,Nunez Rodolfo,Anderlini Paolo,Pro Barbara,Khouri Issa,Younes Anas,Hagemeister Fredrick,Kwak Larry,Fayad Luis

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Hodgkin's Disease

2. Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group.

3. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.

4. High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients

5. Comparison Between Conventional Salvage Therapy and High-Dose Therapy With Autografting for Recurrent or Refractory Hodgkin's Disease

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the best salvage therapy for Hodgkin lymphoma?;Current Opinion in Oncology;2024-06-20

2. A Deeper Depth of Response After Salvage Therapy Improves Outcomes of Autologous Stem Cell Transplantation in Relapsed Lymphoma and the Feasibility of Non-controlled Rate Freezing of Peripheral Blood Stem Cells;Cureus;2024-03-24

3. Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma;British Journal of Haematology;2023-10-18

4. Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma;JAMA Oncology;2023-05-01

5. The role of transplantation in Hodgkin lymphoma;Frontiers in Oncology;2023-01-26